Notable companies
The most notable companies in this group are Amgen (NASDAQ:AMGN), Gilead Sciences (NASDAQ:GILD), Regeneron Pharmaceuticals (NASDAQ:REGN), IQVIA Holdings (NYSE:IQV), Biogen (NASDAQ:BIIB), Illumina (NASDAQ:ILMN), Moderna (NASDAQ:MRNA), Incyte Corp (NASDAQ:INCY), Sarepta Therapeutics (NASDAQ:SRPT), Exelixis (NASDAQ:EXEL).
Industry description
The investment seeks to track the investment results of the NYSE Biotechnology Index composed of U.S.-listed equities in the biotechnology sector.
The fund generally will invest at least 80% of its assets in the component securities of its underlying index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. It is non-diversified.
Market Cap
The average market capitalization across the iShares Biotechnology ETF ETF is 6.17B. The market cap for tickers in the group ranges from 15.83M to 151.69B. AMGN holds the highest valuation in this group at 151.69B. The lowest valued company is MRNS at 15.83M.
High and low price notable news
The average weekly price growth across all stocks in the iShares Biotechnology ETF ETF was 129%. For the same ETF, the average monthly price growth was 124%, and the average quarterly price growth was 341%. QURE experienced the highest price growth at 149%, while BLUE experienced the biggest fall at -47%.
Volume
The average weekly volume growth across all stocks in the iShares Biotechnology ETF ETF was -31%. For the same stocks of the ETF, the average monthly volume growth was -31% and the average quarterly volume growth was -0%
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Valuation Rating: 61
P/E Growth Rating: 79
Price Growth Rating: 57
SMR Rating: 88
Profit Risk Rating: 82
Seasonality Score: 3 (-100 ... +100)